The prevalence of pre-thyroidectomy thyroid function test abnormalities among patients with differentiated thyroid carcinoma: A descriptive study
Publish place: Iranian Journal of Nuclear Medicine، Vol: 31، Issue: 1
Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 149
This Paper With 5 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IRJNM-31-1_007
تاریخ نمایه سازی: 4 بهمن 1401
Abstract:
Introduction: The present study aims to assess pre-thyroidectomy thyroid hormone disturbances among patients suffering from differentiated thyroid carcinoma (DTC).Methods: This retrospective study was performed from September ۲۰۲۰ to March ۲۰۲۱. We analyzed the hospital files of ۷۱۰ patients with DTC who underwent thyroidectomy and referred to nuclear medicine department from April ۲۰۱۳ to September ۲۰۱۹. Demographics, TNM stage, pre-surgery thyroid function tests, time-interval to achieve a complete response, recurrence rate, one-year response, final response, and the need for alternative treatment modalities were extracted. Then, we analyzed the potential association of pre-surgery TSH levels with the initial disease stage and treatment response. Chi-Square, Analysis-of-variance, and Kruskal-Wallis tests were used where appropriate.Results: The mean age of participants was ۴۰.۳۹ ± ۱۳.۸۵ years. History of Hashimoto's disease was detected in ۱۳۰ (۱۸.۳%) patients. Multi-focal DTC was found in ۲۲۱ (۳۱.۲%) patients. Lymph node involvement was significantly higher among men (p = ۰.۰۰۱). Men also had significantly higher thyroglobulin levels (p = ۰.۰۲۵). No statistically significant association was found between pre-surgery thyroid function status and TNM stage or multifocality of the malignancy. Baseline thyroid function tests also did not show a statistically significant relationship with thyroglobulin, anti-thyroglobulin antibody, time to first excellent response, and follow-up duration.Conclusion: Baseline thyroid function status may not change the outcome of DTC. It could also be plausible that thyroid dysfunction before surgery would not increase invasiveness nor impact the treatment-response of the tumor compared to euthyroid patients.
Authors
Somaye Barashki
Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Atena Aghaei
Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Seyed Rasoul Zakavi
Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Fatemeh Mohammad Bagherpour
Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Susan Shafiei
Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Hadis Mohammadzadeh Kosari
Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :